Target intelligence / Profile preview

Growth hormone secretagogue receptor 1 (GHSR1 (also commonly abbreviated as GHS-R1a for the active isoform))

Target
GHSR1 (also commonly abbreviated as GHS-R1a for the active isoform)
Molecular classification
G protein-coupled receptor (GPCR), Class A Rhodopsin-like GPCR, Receptor
01

Overview

The **Growth hormone secretagogue receptor 1** (**GHSR1**, often called the *ghrelin receptor*) is a class A rhodopsin-like **G protein-coupled receptor** that mediates the actions of ghrelin—a gut-derived peptide involved in stimulating appetite (“hunger hormone”), regulating energy balance/fat accumulation, modulating reward/mood circuits in the brain, promoting growth hormone release from the pituitary gland, and influencing glucose metabolism. The canonical active form is known as **GHSR1a**. This receptor exhibits complex signaling properties by coupling with several types of intracellular proteins (notably various subtypes of α subunits like Gαq/11—which increases intracellular calcium—and others), allowing it to regulate diverse physiological processes. It also displays high constitutive activity even without ligand binding. Importantly, it can form heterodimers with other GPCRs—including dopamine receptors—which further modulates its function. Because dysregulation of this pathway contributes to obesity and related metabolic diseases—and possibly neuropsychiatric conditions—the ghrelin/GHSR system has been extensively studied as a therapeutic target. However, drug development has been challenging due to pleiotropic effects across multiple organ systems and difficulties achieving selective modulation without adverse outcomes.

Other names
Ghrelin receptorGrowth hormone secretagogue receptorGHSRGHS-RGH-releasing peptide receptor
02

Mechanism of action

Agonists stimulate the receptor to increase growth hormone release, appetite, and energy storage via multiple intracellular pathways including activation of phospholipase C through Gαq/11 proteins leading to increased intracellular calcium; also activates other pathways via different G-protein couplings such as Gαi/o/z and Gα12/13; can recruit β-arrestin for alternative signaling or desensitization. Antagonists block these effects by inhibiting ghrelin binding or downstream signaling.

03

Biological functions

Signal transductionAppetite regulationEnergy homeostasis and fat accumulationMood regulation and cognitive functionsReward processing and behavior modulationGrowth hormone secretion
04

Disease associations

ObesityMetabolic disordersNeuropsychiatric disorders (e.g., anxiety, mood)Potential roles in cardiovascular disease, diabetes, and neurodegeneration (based on broader literature)
05

Safety considerations

Modulation affects multiple physiological systems beyond appetite/metabolism including mood, cognition, reward circuitry, growth hormone axis.Broad blockade may cause undesired side effects such as altered mood/cognition or impaired growth hormone secretion.High constitutive activity (~50% of maximal) complicates pharmacological targeting; potential off-target effects due to heterodimerization with other GPCRs like dopamine receptors.
06

Interacting drugs

YIL781 (biased ligand)

2 more in the full profile.

07

Biomarkers

Circulating acyl-ghrelin levels may serve as a biomarker of pathway activity or patient selection in metabolic studies.No widely established clinical biomarkers specific for therapeutic monitoring.

Beyond the preview

Go deeper on Growth hormone secretagogue receptor 1 (GHSR1 (also commonly abbreviated as GHS-R1a for the active isoform)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Growth hormone secretagogue receptor 1 (GHSR1 (also commonly abbreviated as GHS-R1a for the active isoform)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call